Pages that link to "Q28371563"
Jump to navigation
Jump to search
The following pages link to Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group (Q28371563):
Displaying 50 items.
- Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction (Q22337231) (← links)
- Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children (Q24197682) (← links)
- Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults (Q24200804) (← links)
- Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults (Q24202489) (← links)
- Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma (Q24244152) (← links)
- Beclomethasone versus placebo for chronic asthma (Q24244887) (← links)
- Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma (Q24245147) (← links)
- Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children (Q24247433) (← links)
- Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma (Q24247489) (← links)
- TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids (Q24558608) (← links)
- The role of LTA4H and ALOX5AP genes in the risk for asthma in Latinos (Q24626218) (← links)
- Leukotriene-receptor antagonists versus placebo in the treatment of asthma in adults and adolescents: a systematic review and meta-analysis (Q26782714) (← links)
- Bitter taste receptors on airway smooth muscle as targets for novel bronchodilators (Q26830082) (← links)
- Asthma phenotypes: the intriguing selective intervention with Montelukast (Q28071735) (← links)
- The Danish National Database for Asthma: establishing clinical quality indicators (Q28074257) (← links)
- The role of antileukotrienes in the treatment of asthma (Q28185790) (← links)
- An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma (Q28189893) (← links)
- Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial (Q28192038) (← links)
- The role of leukotrienes in asthma (Q28196934) (← links)
- Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand (Q28287399) (← links)
- Antileukotriene agents for the treatment of lung disease (Q28293842) (← links)
- Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials (Q28344299) (← links)
- The effects of airway microbiome on corticosteroid responsiveness in asthma (Q28392911) (← links)
- GPR17 regulates immune pulmonary inflammation induced by house dust mites (Q28512834) (← links)
- Genetic predictors associated with improvement of asthma symptoms in response to inhaled corticosteroids (Q28943401) (← links)
- Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down". (Q30447195) (← links)
- The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes (Q30978892) (← links)
- Montelukast: data from clinical trials in the management of asthma (Q31448541) (← links)
- Influence of leukotriene pathway polymorphisms on response to montelukast in asthma (Q33227414) (← links)
- The expanding role of leukotriene receptor antagonists in chronic asthma. (Q33268060) (← links)
- Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers (Q33487035) (← links)
- Monitoring asthma control using claims data and patient-reported outcomes measures (Q33502728) (← links)
- Asthma in the elderly: a double-blind, placebo-controlled study of the effect of montelukast (Q33568746) (← links)
- Update in internal medicine (Q33588350) (← links)
- Role of Leukotrienes and Leukotriene Modifiers in Asthma (Q33664150) (← links)
- The role of pharmacogenomics in improving the management of asthma (Q33669054) (← links)
- Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists (Q33677296) (← links)
- Treating children with asthma. A review of drug therapies (Q33729027) (← links)
- Evolving Concepts of Asthma (Q33735605) (← links)
- Effectiveness of montelukast administered as monotherapy or in combination with inhaled corticosteroid in pediatric patients with uncontrolled asthma: a prospective cohort study (Q33755127) (← links)
- The problems of treating adolescent asthma: what are the alternatives to inhaled therapy? (Q33784512) (← links)
- Genetic and environmental interaction in allergy and asthma (Q33788969) (← links)
- Bitter taste receptor function in asthmatic and nonasthmatic human airway smooth muscle cells (Q33799618) (← links)
- Effects of antileukotrienes in the treatment of asthma (Q33836725) (← links)
- Vitamin D levels, lung function, and steroid response in adult asthma (Q33845615) (← links)
- The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial (Q33858088) (← links)
- Why does airway inflammation persist? Is it leukotrienes? (Q33860277) (← links)
- Asthma in sickle cell disease: implications for treatment. (Q33872120) (← links)
- Clinical evidence with montelukast in the management of chronic childhood asthma (Q33878228) (← links)
- Tolerability of montelukast. (Q33878233) (← links)